For the Inventor, By the Inventor

Enter assignee name

Amsterdam, Netherlands

Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis

USPTO Granted Patents = 12

EPO Patents = 14

Trademarks = 2

Forward Citations = 3

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Theodoor Jacques Marie Ruers (3 out of 4 patents)

Rene Bernards (2 out of 6 patents)

Divya Reddy Lenkala (1 out of 2 patents)

4. Marit M Van Buuren (1 out of 2 patents)

5. Joost Huibert Van Den Berg (1 out of 1 patent)

6. Jessica Kohler (1 out of 2 patents)

7. Matthew Goldstein (1 out of 2 patents)

8. Ed Fritsch (1 out of 2 patents)

9. Renate De Boer (1 out of 2 patents)

10. Ton Schumacher (1 out of 2 patents)

11. Noor Bakker (1 out of 2 patents)

12. Remko Schotte (1 out of 3 patents)

13. Liqin Wang (1 out of 1 patent)

14. Rodrigo Leite De Oliveira (1 out of 1 patent)

15. Hergen Spits (1 out of 25 patents)

12 patents: Sort by Forward Citations

1. 12161325 - Surgical forceps and stapler (2024-12-10),

2. 12138395 - Heat and moisture exchanger (2024-11-12),

3. 11981664 - Photoresponsive nutlin derivatives and uses thereof (2024-05-14),

4. 11629179 - TWEAK-receptor agonists for use in combination with immunotherapy of a cancer (2023-04-18),

5. 11523869 - Method and system of providing visual information about a location and shape of a tumour under a body surface of a human or animal body (2022-12-13),

6. 11504395 - Oral pyrophosphate for use in reducing tissue calcification (2022-11-22),

7. 11162072 - T cell manufacturing compositions and methods (2021-11-02),

8. 10864179 - Histone deacetylase inhibitors for the use in the treatment of drug resistant melanoma (2020-12-15),

9. 10753862 - Method, apparatus and software for detection and localization of hidden defects in optically diffuse media (2020-08-25),

10. 10690658 - Means and methods for determining T cell recognition (2020-06-23),

11. 10398696 - Combinations for treatment of cancer (2019-09-03),

12. 10351845 - Assays to identify genetic elements affecting phenotype (2019-07-16),

Stichting Het Nederlands Kanker Instituut-antoni Van Leeuwenhoek Ziekenhuis (NKI-AVL) is a leading comprehensive cancer center in the Netherlands. With a strong focus on research, treatment, and education, NKI-AVL offers state-of-the-art cancer care to patients. The institute is known for its pioneering work in cancer research and innovative treatment approaches.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#46 in Amsterdam

#533 in Netherlands

#46,724 in the World

Amsterdam, Netherlands

Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis

Forward Citations = 3

49 inventors:

Theodoor Jacques Marie Ruers (3 out of 4 patents)

Rene Bernards (2 out of 6 patents)

Divya Reddy Lenkala (1 out of 2 patents)

4. Marit M Van Buuren (1 out of 2 patents)

5. Joost Huibert Van Den Berg (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

Loading…